Effects of Combining Rapamycin and Resveratrol on Apoptosis and Growth of TSC2-Deficient Xenograft Tumors
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of Combining Rapamycin and Resveratrol on Apoptosis and Growth of TSC2-Deficient Xenograft Tumors
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
Volume 53, Issue 5, Pages 637-646
Publisher
American Thoracic Society
Online
2015-04-06
DOI
10.1165/rcmb.2015-0022oc
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Combination of Rapamycin and Resveratrol Blocks Autophagy and Induces Apoptosis in Breast Cancer Cells
- (2015) Anya Alayev et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Resveratrol prevents rapamycin-induced upregulation of autophagy and selectively induces apoptosis in TSC2-deficient cells
- (2014) Anya Alayev et al. CELL CYCLE
- Phosphoproteomics Reveals Resveratrol-Dependent Inhibition of Akt/mTORC1/S6K1 Signaling
- (2014) Anya Alayev et al. JOURNAL OF PROTEOME RESEARCH
- Changes in Lung Function and Chylous Effusions in Patients With Lymphangioleiomyomatosis Treated With Sirolimus
- (2013) Angelo M. Taveira-DaSilva et al. ANNALS OF INTERNAL MEDICINE
- mTOR signaling for biological control and cancer
- (2013) Anya Alayev et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The role of S6K1 in ER-positive breast cancer
- (2012) Marina K. Holz CELL CYCLE
- Lymphangioleiomyomatosis — a wolf in sheep’s clothing
- (2012) Elizabeth P. Henske et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeted Approaches toward Understanding and Treating Pulmonary Lymphangioleiomyomatosis (LAM)
- (2012) Stephen R. Hammes et al. Hormones & Cancer
- Sirolimus Therapy for Angiomyolipoma in Tuberous Sclerosis and Sporadic Lymphangioleiomyomatosis: A Phase 2 Trial
- (2011) D. M. Davies et al. CLINICAL CANCER RESEARCH
- Efficacy and Safety of Sirolimus in Lymphangioleiomyomatosis
- (2011) Francis X. McCormack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multicenter Phase 2 Trial of Sirolimus for Tuberous Sclerosis: Kidney Angiomyolipomas and Other Tumors Regress and VEGF- D Levels Decrease
- (2011) Sandra L. Dabora et al. PLoS One
- Tumorigenesis in tuberous sclerosis complex is autophagy and p62/sequestosome 1 (SQSTM1)-dependent
- (2011) A. Parkhitko et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Estrogen promotes the survival and pulmonary metastasis of tuberin-null cells
- (2009) Jane J. Yu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Lymphangioleiomyomatosis
- (2008) Francis X. McCormack CHEST
- Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or Lymphangioleiomyomatosis
- (2008) John J. Bissler et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now